retatrutide type 2 diabetes trial results 2024 Effects of retatrutide, dulaglutide, and placebo on gastric emptying in The power of three: Retatrutide's – New Kind of Diabetes Drug

The FDA warns about a rare but serious side effect: gastroparesis

Wegovy is now uniquely positioned as the first and only GLP-1 treatment approved for MASH, complementing the already proven weight loss, cardiovascular benefits and extensive body of evidence linked to semaglutide, said Dr

However, lean body mass also decreased by 10.9% in the tirzepatide group versus 2.6% with placebo

Calcium, iron and neuronal function

Additionally, B12 is essential for the conversion of homocysteine to methionine, preventing the accumulation of homocysteine, which is associated with cardiovascular risk

This dual action improves blood sugar regulation, reducing energy crashes and cravings triggered by glucose fluctuations